Symbols

IART

Integra Lifesciences Holdings·NASDAQ

--(--)

IART fundamentals

Integra Lifesciences Holdings (IART) Revenue Breakdown: Q3 2025 Business & Regional Performance
Integra Lifesciences Holdings (IART) reported total revenue of 402.06M USD in Q3 2025, with its core business segment Specialty Surgical Solutions contributing 72.77%. Regionally, United States remained the largest market, accounting for 73.58% of total revenue. Explore Integra Lifesciences Holdings's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.

By Business

No Data

By Region

No Data

You can ask Aime

What factors drove the changes in Integra Lifesciences Holdings's revenue and profit?

Did Integra Lifesciences Holdings beat or miss consensus estimates last quarter?

What is the revenue and EPS growth rate for Integra Lifesciences Holdings year over year?

What is the market's earnings forecast for Integra Lifesciences Holdings next quarter?

What is Integra Lifesciences Holdings's latest dividend and current dividend yield?

What were the key takeaways from Integra Lifesciences Holdings’s earnings call?

What does Integra Lifesciences Holdings do and what are its main business segments?

What guidance did Integra Lifesciences Holdings's management provide for the next earnings period?